{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T04:23:20Z","timestamp":1742703800322,"version":"3.40.2"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.xphs.2024.12.024","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T20:20:16Z","timestamp":1737058816000},"page":"1464-1471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanism of low molecular weight impurity formation in an IgG1 monoclonal antibody formulation"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4244-5323","authenticated-orcid":false,"given":"Pinaki","family":"Basu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5160-7832","authenticated-orcid":false,"given":"Nidhi","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigireddi","family":"Indra Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Nanath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sireesha Goswamy","family":"Kaligatla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giridhar","family":"Sivalanka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9216-6937","authenticated-orcid":false,"given":"Veerabhadra Madurai","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovisha","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"A Nankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi Kumar","family":"Marikanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0794-2609","authenticated-orcid":false,"given":"Murali","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.xphs.2024.12.024_bib0001","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.addr.2011.06.011","article-title":"Interactions of formulation excipients with proteins in solution and in the dried state","volume":"63","author":"Ohtake","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2024.12.024_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejpb.2022.05.017","article-title":"Simplified choice of suitable excipients within biologics formulation design using protein-protein interaction- and water activity-maps","volume":"176","author":"Stolzke","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.12.024_bib0003","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.xphs.2015.11.002","article-title":"Immunogenicity of therapeutic protein aggregates","volume":"105","author":"Moussa","year":"2016","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2024.12.024_bib0004","article-title":"Effects of protein aggregates: an immunologic perspective","volume":"59","author":"Rosenberg","year":"2006","journal-title":"AAPS J"},{"issue":"8","key":"10.1016\/j.xphs.2024.12.024_bib0005","article-title":"Fragmentation of a recombinant monoclonal antibody at various pH","volume":"25","author":"Liu","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2024.12.024_bib0006","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/jphp.12688","article-title":"Novel chemical degradation pathways of proteins mediated by tryptophan oxidation: tryptophan side chain fragmentation","volume":"70","author":"Schoneich","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2024.12.024_bib0007","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11095-013-1199-9","article-title":"Oxidation of therapeutic proteins and peptides: structural and biological consequences","volume":"31","author":"Torosantucci","year":"2014","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2024.12.024_bib0008","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.xphs.2021.11.024","article-title":"Oxidation and deamidation of monoclonal antibody products: potential impact on stability, biological activity, and efficacy","volume":"111","author":"Gupta","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.12.024_bib0009","first-page":"1","article-title":"Quality by design approaches to formulation robustness-an antibody case study","author":"Wurth","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.12.024_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4161\/mabs.3.3.15608","article-title":"Fragmentation of monoclonal antibodies","author":"Vlasak","year":"2011","journal-title":"MAbs"},{"key":"10.1016\/j.xphs.2024.12.024_bib0011","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"Swiss-Model: homology modelling of Protein structures and complexes","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xphs.2024.12.024_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09654-8","article-title":"Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology","author":"Bertoni","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2024.12.024_bib0013","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","article-title":"QMEANDisCO- distance constraints applied on model quality estimation","author":"Studer","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xphs.2024.12.024_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/elps.200900140","article-title":"Automated comparative protein structure modelling with SWISS-MODEL and SWISS-PdbViewer:a historical perspective","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.xphs.2024.12.024_bib0015","doi-asserted-by":"crossref","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","article-title":"The SWISS_MODEL repository-new features and functionality","author":"Bienert","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xphs.2024.12.024_bib0016","unstructured":"Schr\u00f6dinger L. & DeLano W. \u201cPyMOL,\u201d Retrieved from http:\/\/www.pymol.org\/pymol, 2020."},{"key":"10.1016\/j.xphs.2024.12.024_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080635","article-title":"Maximum allowed solvent accessibilities of residues in proteins","author":"Tien","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2024.12.024_bib0018","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xphs.2024.12.024_bib0019","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jcc.20832","article-title":"FACTS: fast analytical continuum treatment of solvation","author":"Haberth\u00fcr","year":"2008","journal-title":"J Comput Chem"},{"key":"10.1016\/j.xphs.2024.12.024_bib0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1399-3011.1996.tb01105.x","article-title":"Specific cleavage of immunoglobulin G by copper ions","author":"Smith","year":"1996","journal-title":"Int J Pept Protein Res"},{"key":"10.1016\/j.xphs.2024.12.024_bib0021","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/19420862.2015.1062193","article-title":"Metal ion interactions with mAbs: Part 1 pH and conformation modulate copper-mediated site-specific fragmentation of the IgG1 hinge region","author":"Kwong Glover","year":"2015","journal-title":"MAbs"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924006270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924006270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T22:23:16Z","timestamp":1742682196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924006270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0022354924006270"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.12.024","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of low molecular weight impurity formation in an IgG1 monoclonal antibody formulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}